1. Home
  2. GRNQ vs ADXN Comparison

GRNQ vs ADXN Comparison

Compare GRNQ & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • ADXN
  • Stock Information
  • Founded
  • GRNQ 2013
  • ADXN 2002
  • Country
  • GRNQ Malaysia
  • ADXN Switzerland
  • Employees
  • GRNQ 46
  • ADXN N/A
  • Industry
  • GRNQ EDP Services
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRNQ Technology
  • ADXN Health Care
  • Exchange
  • GRNQ Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • GRNQ 7.0M
  • ADXN 8.2M
  • IPO Year
  • GRNQ 2018
  • ADXN N/A
  • Fundamental
  • Price
  • GRNQ $0.92
  • ADXN $7.10
  • Analyst Decision
  • GRNQ
  • ADXN Strong Buy
  • Analyst Count
  • GRNQ 0
  • ADXN 1
  • Target Price
  • GRNQ N/A
  • ADXN $30.00
  • AVG Volume (30 Days)
  • GRNQ 15.8K
  • ADXN 8.5K
  • Earning Date
  • GRNQ 03-27-2025
  • ADXN 03-24-2025
  • Dividend Yield
  • GRNQ N/A
  • ADXN N/A
  • EPS Growth
  • GRNQ N/A
  • ADXN N/A
  • EPS
  • GRNQ N/A
  • ADXN 0.06
  • Revenue
  • GRNQ $2,727,344.00
  • ADXN $701,260.00
  • Revenue This Year
  • GRNQ N/A
  • ADXN N/A
  • Revenue Next Year
  • GRNQ N/A
  • ADXN N/A
  • P/E Ratio
  • GRNQ N/A
  • ADXN $0.96
  • Revenue Growth
  • GRNQ N/A
  • ADXN N/A
  • 52 Week Low
  • GRNQ $0.80
  • ADXN $6.67
  • 52 Week High
  • GRNQ $2.24
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 41.21
  • ADXN 44.29
  • Support Level
  • GRNQ $0.92
  • ADXN $6.77
  • Resistance Level
  • GRNQ $0.96
  • ADXN $8.00
  • Average True Range (ATR)
  • GRNQ 0.05
  • ADXN 0.83
  • MACD
  • GRNQ -0.00
  • ADXN -0.10
  • Stochastic Oscillator
  • GRNQ 15.46
  • ADXN 10.75

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management, cross-border listing advisory services, and transaction services. It also operates a venture capital business. Its segments include Service business engaged in the provision of corporate advisory and business solution services; and Real estate business engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: